How has been the historical performance of Maitreya Medica.?

Answer:The historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years. Breakdown: Maitreya Medica's net sales have seen a decline from INR 49.41 crore in March 2022 to INR 46.66 crore in March 2025, with a peak of INR 47.80 crore in March 2024. Total operating income mirrored this trend, peaking in March 2024 before dropping to INR 46.66 crore in March 2025. The company's operating profit (PBDIT) also decreased from INR 7.82 crore in March 2023 to INR 5.45 crore in March 2025, reflecting a decline in operating profit margin from 18.41% to 10.42%. Profit before tax followed a similar downward trajectory, falling from INR 5.93 crore in March 2023 to INR 3.21 crore in March 2025. Consequently, profit after tax decreased from INR 4.25 crore in March 2023 to INR 1.87 crore in March 2025, resulting in a PAT margin decline from 10.79% to 4.01%. On the balance sheet, total liabilities increased from INR 24.49 crore in March 2022 to INR 47.99 crore in March 2025, while total assets rose from INR 24.49 crore to INR 47.99 crore during the same period. Cash flow from operating activities improved to INR 5 crore in March 2025, contrasting with a negative cash flow of INR 2 crore in March 2024. Overall, Maitreya Medica's financial performance indicates a challenging environment with declining profitability but some improvement in cash flow from operations.